# DEVELOPMENT AND MANUFACTURE OF ORAL AND TOPICAL DOSAGE FORMS

> **NIH NIH N02** · IRISYS, INC. · 2020 · $9,916

## Abstract

Stability Testing of Decitabine Capsules according to Document Number X-QC-013-02.

## Key facts

- **NIH application ID:** 10269377
- **Project number:** 261201500009I-0-759102000001-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** GERALD YAKATAN
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,916
- **Award type:** —
- **Project period:** 2019-11-20 → 2019-12-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10269377

## Citation

> US National Institutes of Health, RePORTER application 10269377, DEVELOPMENT AND MANUFACTURE OF ORAL AND TOPICAL DOSAGE FORMS (261201500009I-0-759102000001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10269377. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*